Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
This study has been terminated.
( See termination reason in detailed description )
Study NCT01009593   Information provided by Abbott

First Received on October 14, 2009.   Last Updated on September 7, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial